Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 3:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2401–2424 of 2,761 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: HIV-1 Infections
Interventions: HAART, T cells; Drug · Biological
Lead sponsor: University of Pennsylvania; Other
Eligibility: Not listed
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: HIV Infections
Interventions: SAV001-H; Biological
Lead sponsor: Sumagen; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Solid Tumor, Adult
Interventions: IMSA101, Immune checkpoint inhibitor (ICI), Immuno-oncology (IO) therapy; Drug
Lead sponsor: ImmuneSensor Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 6
States / cities: Scottsdale, Arizona • La Jolla, California • Chicago, Illinois + 3 more

Conditions: Advanced Solid Tumors Cancer, MSI-H Cancer
Interventions: NDI-219216; Drug
Lead sponsor: Nimbus Wadjet, Inc.; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 11
States / cities: Los Angeles, California • Chicago, Illinois • Louisville, Kentucky + 8 more

Conditions: Medical Knowledge, Clinical Performance
Interventions: Debriefing of high-fidelity sepsis simulation scenarios, Placebo: Debriefing of high-fidelity non-sepsis simulation scenarios; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 20 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Substance Use, Parenting, Communication
Interventions: Media Ready Parent, Active Control Program; Behavioral
Lead sponsor: Innovation Research & Training; Other
Eligibility: 10 Years and older
Enrollment: 576 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Spinal Cord Injuries
Interventions: High Intensity Interval Exercise Training Group; Behavioral
Lead sponsor: Arkansas Colleges of Health Education; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Fort Smith, Arkansas

Conditions: Carpal Tunnel Syndrome
Interventions: Academic Coursework, Work-Related Hand Activities; Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 176 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2023
U.S. locations: 3
States / cities: Loma Linda, California • Los Angeles, California

Conditions: Beta Thalassemia Intermedia, Sickle Cell Disease
Interventions: Benserazide Only Product; Drug
Lead sponsor: Phoenicia BioScience; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 4
States / cities: Oakland, California • Boston, Massachusetts • Weston, Massachusetts + 1 more

Conditions: SARS-CoV-2, COVID-19
Interventions: CV0701 mRNA COVID-19 Vaccine (Low dose), CV0701 mRNA COVID-19 Vaccine (Medium dose), CV0701 mRNA COVID-19 Vaccine (High dose), CV0601 mRNA COVID-19 Vaccine, Control vaccine, CV0801 mRNA COVID-19 Vaccine; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 692 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Sacramento, California • Hollywood, Florida • Peoria, Illinois

Conditions: Obesity, Obesity, Childhood, Weight Gain, Weight Gain Trajectory
Interventions: THRIVE 2.0; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Day and older
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Chronic Migraine
Interventions: HD-tDCS Active Protocol, HD-tDCS Sham Protocol; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Substance Use Disorders, HIV, Depression, Anxiety
Interventions: Clinic-based screening and behavioral interventions; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 10,821 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Oakland, California

Conditions: Pain, Substance Use, Opioid Misuse, Quality of Life
Interventions: M2VA Pain Care Pathway (M2VAPCP), Implementation Facilitation; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 1,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Spinal Cord Injury
Interventions: Exercise; Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Parkinson Disease
Interventions: Placebo, inosine; Drug
Lead sponsor: The Parkinson Study Group; Network
Eligibility: 30 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 16
States / cities: Los Angeles, California • Manchester, Connecticut • New Haven, Connecticut + 12 more

Conditions: Diabetes Mellitus, Type 1, Behavior, Health
Interventions: DVx-T1D™ app; Behavioral
Lead sponsor: Carnegie Mellon University; Other
Eligibility: 6 Years to 12 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy, Non-obstructive Hypertrophic Cardiomyopathy
Interventions: mavacamten; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 31
States / cities: Scottsdale, Arizona • Los Angeles, California • San Francisco, California + 26 more

Conditions: Autism Spectrum Disorder
Interventions: N acetyl cysteine, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 3 Years to 12 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Neuroendocrine Tumors
Interventions: fosbretabulin tromethamine; Drug
Lead sponsor: Mateon Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 5
States / cities: Stanford, California • Lexington, Kentucky • The Bronx, New York + 2 more

Conditions: Hypogonadism
Interventions: TSX-002; Drug
Lead sponsor: TesoRx Pharma, LLC; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Ethanol Intoxication
Interventions: ADX-629, Placebo; Drug
Lead sponsor: Aldeyra Therapeutics, Inc.; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Alzheimer Disease and Related Dementias, Cognition, Mobility Disability
Interventions: Personalized Transcranial Direct Current Stimulation (tDCS), Active-Sham; Other
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 65 Years to 90 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Roslindale, Massachusetts

Conditions: Overweight (BMI > 25), Obesity (BMI>30), Hs-CRP
Interventions: Avocado, Control; Other
Lead sponsor: Midwest Center for Metabolic and Cardiovascular Research; Other
Eligibility: 21 Years to 74 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois • Las Vegas, Nevada

Search by objective public record fields.

CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome

Feasibility Study of a Web-based Program to Help Parents of Middle School Students Effectively Communicate With Their Children About Substance Use

Functional Interval Training for People With Spinal Cord Injury and Their Care Partners

Musculoskeletal Health of the Upper Extremity in Emerging Health Professionals

The BENeFiTS Trial in Beta Thalassemia Intermedia

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

A Novel Obesity Prevention Program for High-Risk Infants in Primary Care

Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)

Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care

M2VA Pain Care Pathway

Effects of Exercise in People With Paraplegia

Safety of Urate Elevation in Parkinson's Disease

Game-based Pediatric Diabetes Education

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

Oral Testosterone for the Treatment of Hypogonadism

A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels

Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.